Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Asset Utilization Ratio (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.01 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 98.54% to 0.01 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01, a 98.54% decrease, with the full-year FY2024 number at 0.46, up 89.43% from a year prior.
  • Asset Utilization Ratio was 0.01 for Q3 2025 at Precision Biosciences, down from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.53 in Q4 2021 to a low of 0.01 in Q3 2025.
  • A 5-year average of 0.3 and a median of 0.3 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 321.35% in 2021, then crashed 98.54% in 2025.
  • Precision Biosciences' Asset Utilization Ratio stood at 0.53 in 2021, then plummeted by 81.31% to 0.1 in 2022, then soared by 205.43% to 0.3 in 2023, then surged by 57.76% to 0.47 in 2024, then plummeted by 98.55% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Asset Utilization Ratio are 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.39 (Q1 2025).